Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Researchers use B-cell ELISPOT assay to measure DP6-001-induced gp120-specific B cell responses

May 5, 2014

French researchers disclose new agents for HIV infection

April 30, 2014

FDA accepts refiling of cobicistat and elvitegravir NDAs for HIV

April 23, 2014

ViiV Healthcare launches dolutegravir in Japan

April 17, 2014

Bristol-Myers Squibb files NDA for HIV-1 fixed-dose combination tablet

April 15, 2014

ViiV Healthcare and MPP to improve access to dolutegravir

April 7, 2014

Janssen submits NDA to the FDA for darunavir/cobicistat fixed-dose combination tablet

April 2, 2014

Tivicay obtains approval in Japan for HIV

March 25, 2014

Chinese group presents novel agents for HIV and HBV infection

March 20, 2014

Peptide triazole KR-13 induces cell-free HIV-1 virolysis

March 19, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...